Shilpa Medicare Share Price

703.85-7.61 (-1.07%)
Volume: 1,54,506

Closed
Last Updated On: 20 May, 2025, 03:29 PM IST

STOCK SCORE

ETPrime Only

TECHNICALS
COMPARE

Shilpa Medicare Share Price

703.85-7.61 (-1.07%)
Volume: 1,54,506

Overview
News
Analysis
Recos
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About

Shilpa Medicare share price insights

Employee & Interest Expense
Company has spent 7.97% of its operating revenues towards interest expenses and 24.44% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Shilpa Medicare Share Price Update
Shilpa Medicare Ltd. share price moved down by -1.07% from its previous close of Rs 711.45. Shilpa Medicare Ltd. stock last traded price is 703.85
Share Price Value
Today/Current/Last 703.85711.00
Previous Day 711.45712.45

Share Price	Value
Today/Current/Last	703.85711.00
Previous Day	711.45712.45

InsightsShilpa Medicare

Do you find these insights useful?

hate it
meh
love it

Key Metrics

PE Ratio

(x)

77.95

EPS - TTM

(₹)

9.03

MCap

(₹ Cr.)

6,855.14

Sectoral MCap Rank

PB Ratio

(x)

3.87

Div Yield

(%)

0.00

Face Value

(₹)

1.00

Beta

-0.14

VWAP

(₹)

710.38

52W H/L

(₹)

959.50 / 417.60

Shilpa Medicare Share Price Returns

1 Day	-1.07%
1 Week	5.14%
1 Month	5.29%
3 Months	3.26%
1 Year	40.35%
3 Years	66.97%
5 Years	99.17%

ET Stock ScreenersTop Score Companies

Check whether Shilpa Medicare belongs to analysts' top-rated companies list?

View Stock Screeners

Shilpa Medicare News & Analysis

View all Shilpa Medicare Share News & Announcements

Shilpa Medicare Share Analysis

Unlock Stock Score, Analyst' Ratings & Recommendations

View Stock Score on a 10-point scale
See ratings on Earning, Fundamentals, Valuation, Risk & Price
Check stock performance

JOIN ET PRIME

Shilpa Medicare Share Recommendations

Recent Recos

STRONG BUY

Current

Mean Recos by 2 Analysts

Strong
SellSellHoldBuyStrong
Buy

Target₹540
OrganizationAnand Rathi
BUY

Target₹346
OrganizationICICI Securities
REDUCE

Analyst Trends

Ratings	Current	1 Week Ago	1 Month Ago	3 Months Ago
Strong Buy	2	2	2	2
Buy	-	-	-	-
Hold	-	-	-	-
Sell	-	-	-	-
Strong Sell	-	-	-	-
# Analysts	2	2	2	2

View all Stock Recommendations

Insights

Employee & Interest Expense
Company has spent 7.97% of its operating revenues towards interest expenses and 24.44% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)

Quarterly \| Annual	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023
Total Income	320.45	348.79	301.95	294.19	288.70
Total Income Growth (%)	-8.13	15.51	2.64	1.90	-8.29
Total Expenses	267.43	286.07	246.02	242.13	247.25
Total Expenses Growth (%)	-6.52	16.28	1.61	-2.07	-11.85
EBIT	53.02	62.71	55.93	52.06	41.45
EBIT Growth (%)	-15.46	12.12	7.45	25.59	20.79
Profit after Tax (PAT)	31.78	17.94	14.06	24.50	4.58
PAT Growth (%)	77.19	27.56	-42.61	434.93	190.87
EBIT Margin (%)	16.54	17.98	18.52	17.70	14.36
Net Profit Margin (%)	9.92	5.14	4.66	8.33	1.59
Basic EPS (₹)	3.25	1.83	1.46	2.82	0.53

Quarterly \| Annual	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023
Total Income	142.21	151.15	127.57	110.70	86.31
Total Income Growth (%)	-5.91	18.48	15.24	28.26	-11.37
Total Expenses	115.51	99.32	84.93	96.56	79.79
Total Expenses Growth (%)	16.30	16.93	-12.04	21.02	-0.52
EBIT	26.71	51.84	42.64	14.14	6.52
EBIT Growth (%)	-48.48	21.56	201.64	116.96	-62.06
Profit after Tax (PAT)	16.12	30.49	28.35	9.74	2.70
PAT Growth (%)	-47.13	7.55	191.12	261.06	-59.15
EBIT Margin (%)	18.78	34.29	33.42	12.77	7.55
Net Profit Margin (%)	11.34	20.17	22.22	8.80	3.12
Basic EPS (₹)	1.65	3.12	2.94	1.12	0.31

Quarterly \| Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	1,159.77	1,067.51	1,159.77	931.27	924.85
Total Revenue Growth (%)	8.64	-7.95	24.54	0.69	23.79
Total Expenses	1,106.79	1,101.98	1,062.63	795.32	736.45
Total Expenses Growth (%)	0.44	3.70	33.61	7.99	18.15
Profit after Tax (PAT)	31.87	-32.48	60.66	147.78	156.15
PAT Growth (%)	-	-153.54	-58.95	-5.36	39.10
Operating Profit Margin (%)	12.57	2.30	12.07	17.51	21.25
Net Profit Margin (%)	2.76	-3.09	5.29	16.39	17.19
Basic EPS (₹)	3.67	-3.74	7.26	18.13	19.15

Quarterly \| Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	398.90	316.35	397.81	289.30	817.23
Total Revenue Growth (%)	26.10	-20.48	37.51	-64.60	20.29
Total Expenses	350.36	359.08	379.14	252.03	600.35
Total Expenses Growth (%)	-2.43	-5.29	50.43	-58.02	17.22
Profit after Tax (PAT)	26.94	57.19	140.99	184.39	193.72
PAT Growth (%)	-52.90	-59.43	-23.54	-4.81	56.09
Operating Profit Margin (%)	21.23	-8.84	7.76	16.85	27.44
Net Profit Margin (%)	8.69	23.08	39.49	71.73	24.03
Basic EPS (₹)	3.10	6.59	16.24	22.62	20.63

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Assets	3,093.20	2,902.38	2,875.50	2,637.55	1,986.13
Total Assets Growth (%)	6.57	0.93	9.02	32.80	23.36
Total Liabilities	1,293.25	1,128.03	1,064.35	1,170.03	664.68
Total Liabilities Growth (%)	14.65	5.98	-9.03	76.03	58.23
Total Equity	1,799.96	1,774.36	1,811.15	1,467.50	1,321.45
Total Equity Growth (%)	1.44	-2.03	23.42	11.05	11.05
Current Ratio (x)	1.26	0.98	1.45	1.52	1.52
Total Debt to Equity (x)	0.52	0.45	0.37	0.49	0.25
Contingent Liabilities	95.55	186.39	103.86	47.85	50.99

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Assets	2,418.58	2,517.36	2,896.12	2,517.39	2,021.28
Total Assets Growth (%)	-3.92	-13.08	15.04	24.54	21.16
Total Liabilities	275.87	399.77	830.45	879.56	567.86
Total Liabilities Growth (%)	-30.99	-51.86	-5.58	54.89	46.83
Total Equity	2,142.72	2,117.58	2,065.67	1,637.83	1,453.42
Total Equity Growth (%)	1.19	2.51	26.12	12.69	13.41
Current Ratio (x)	1.67	2.63	1.94	1.65	2.52
Total Debt to Equity (x)	0.07	0.14	0.09	0.40	0.22
Contingent Liabilities	655.24	510.05	374.38	207.79	40.60

All figures in Rs Cr, unless mentioned otherwise

View Details

Insights

Decrease in Cash from Investing
Company has used Rs 166.58 cr for investing activities which is an YoY decrease of 40.18%. (Source: Consolidated Financials)

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash flow from Operating Activities	135.34	226.17	105.13	47.07	123.72
Net Cash used in Investing Activities	-166.58	-278.48	-285.50	-404.28	-288.85
Net Cash flow from Financing Activities	46.78	45.80	82.86	436.37	175.50
Net Cash Flow	11.35	-6.51	-97.51	79.03	10.20
Closing Cash & Cash Equivalent	30.43	18.83	25.34	123.34	44.56
Closing Cash & Cash Equivalent Growth (%)	61.62	-25.71	-79.46	176.78	29.69
Total Debt/ CFO (x)	6.91	3.52	6.49	15.38	2.67

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash flow from Operating Activities	8.03	2.08	173.87	69.63	129.79
Net Cash used in Investing Activities	155.82	-94.80	-378.97	-238.13	-295.08
Net Cash flow from Financing Activities	-163.07	87.68	97.23	255.58	170.10
Net Cash Flow	0.78	-5.04	-107.88	87.08	-2.58
Closing Cash & Cash Equivalent	3.13	2.10	7.13	115.01	28.19
Closing Cash & Cash Equivalent Growth (%)	48.98	-70.58	-93.80	308.06	-8.37
Total Debt/ CFO (x)	17.74	138.11	1.12	9.38	2.47

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Return on Equity (%)	1.76	-1.82	3.32	9.99	11.74
Return on Capital Employed (%)	6.03	1.14	6.10	7.75	12.22
Return on Assets (%)	1.03	-1.11	2.10	5.60	7.86
Interest Coverage Ratio (x)	2.75	2.04	5.30	7.22	42.34
Asset Turnover Ratio (x)	0.38	0.36	0.13	34.16	45.71
Price to Earnings (x)	126.58	-61.35	57.14	18.42	12.77
Price to Book (x)	2.21	1.12	1.89	1.84	1.50
EV/EBITDA (x)	19.40	23.03	18.73	15.63	9.59
EBITDA Margin (%)	21.94	11.39	19.03	23.50	26.07

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Return on Equity (%)	1.25	2.70	6.82	11.25	13.32
Return on Capital Employed (%)	3.00	-0.96	1.21	2.12	13.31
Return on Assets (%)	1.11	2.27	4.86	7.32	9.58
Interest Coverage Ratio (x)	6.69	1.18	6.91	10.80	51.10
Asset Turnover Ratio (x)	0.13	0.09	0.13	0.11	39.87
Price to Earnings (x)	149.25	34.84	24.51	14.77	10.30
Price to Book (x)	1.87	0.94	1.67	1.66	1.37
EV/EBITDA (x)	35.91	92.25	57.96	49.67	8.92
EBITDA Margin (%)	37.25	9.94	17.52	25.52	31.78

Financial InsightsShilpa Medicare

Income (P&L)
Cash Flow

- Employee & Interest Expense
  Company has spent 7.97% of its operating revenues towards interest expenses and 24.44% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
- Decrease in Cash from Investing
  Company has used Rs 166.58 cr for investing activities which is an YoY decrease of 40.18%. (Source: Consolidated Financials)

Do you find these insights useful?

hate it
meh
love it

Shilpa Medicare Share Price Forecast

Price
Revenue
Earnings

Get multiple analysts’ prediction on Shilpa Medicare
High, low, medium predictions for Price
Upcoming predictions for Revenue
Details about company earnings
START FREE TRIAL
Get multiple analysts’ prediction on Shilpa Medicare
High, low, medium predictions for Price
Upcoming predictions for Revenue
Details about company earnings
START FREE TRIAL
Get multiple analysts’ prediction on Shilpa Medicare
High, low, medium predictions for Price
Upcoming predictions for Revenue
Details about company earnings
START FREE TRIAL

Shilpa Medicare Technicals

Buy / Sell Signals
Price Analysis
Pivot Levels & ATR
Chart

Stock doesn't have any Buy/Sell Signals.
41%
Positive Movement since
1st Jan 2005 on basis
58%
Negative Movement since
1st Jan 2005 on basis
Exclude
Global Meltdown - 1st Jan 2008 to 10th Nov 2008
Covid Crisis - 1st Feb 2020 to 31st Mar 2020
Pivot Levels
R1 R2 R3 PIVOT S1 S2 S3
Classic - - - - - - -
Average True Range
5 DAYS 14 DAYS 28 DAYS
ATR - - -

	R1	R2	R3	PIVOT	S1	S2	S3
Classic	-	-	-	-	-	-	-

	5 DAYS	14 DAYS	28 DAYS
ATR	-	-	-

Shilpa Medicare Peer Comparison

Shilpa Medicare Stock Performance
Ratio Performance

CHART
TABLE

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Shilpa Medicare Stock Performance	-0.99	5.23	5.38	3.35	40.47	67.11	99.34
Akums Drugs & Pharmaceuticals Ltd. Stock Performance	2.18	9.98	16.04	10.36	0.00	0.00	0.00
Aarti Pharmalabs Stock Performance	-1.37	8.08	14.99	7.22	37.14	0.00	0.00
FDC Ltd Stock Performance	0.81	3.98	5.54	10.59	-6.11	82.19	93.69
Strides Shasun Stock Performance	0.61	3.45	5.52	8.19	-20.93	123.90	63.61
Add More

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Shilpa Medicare	78.01	3.83	1.76	6.03	1.03	7.51	12.57	3.18	3.67	1.26	0.52	6.91
Akums Drugs & Pharmaceuticals Ltd.	59.54	12.33	-0.56	1.36	-0.11	0.00	0.75	0.01	-0.28	1.60	0.69	0.99
Aarti Pharmalabs	27.97	3.83	13.68	17.23	9.37	20.68	18.32	12.87	30.06	2.01	0.20	1.20
FDC Ltd	27.17	3.55	14.55	18.55	12.36	12.52	20.60	15.70	18.58	3.43	0.00	0.00
Strides Shasun	23.56	3.07	-3.32	18.99	-1.20	6.63	13.87	2.00	-7.76	1.03	1.14	3.44
Add More

Annual Ratios (%)

Choose from Peers

Supriya Lifescience
Innova Captab
Sun Pharma Adv Res.
Hikal Ltd
Unichem Labs

Choose from Stocks

See All Parameters

Peers InsightsShilpa Medicare

Do you find these insights useful?

hate it
meh
love it

Shilpa Medicare Shareholding Pattern

QOQ Change
Total Shareholdings

Loading...
Showing Shilpa Medicare Shareholding as on Mar 2025
Category Mar 2025 Dec 2024 Sep 2024 Jun 2024
Promoters 44.23 44.23 44.33 44.39
Pledge 7.92 7.92 7.90 90.41
FII 10.96 9.90 9.59 9.08
DII 7.55 8.27 8.18 7.61
Mutual Funds 4.05 4.89 5.09 5.03
Others 37.26 37.60 37.90 38.92
Showing Shareholding as on Mar 2025
Category No. of Shares Percentage % Change QoQ
Promoters 4,32,49,715 44.23 % 0.00
Pledge 34,25,000 7.92 % 0.00
FII 1,07,30,610 10.96 % 1.06
DII 73,80,255 7.55 % -0.71
MF 39,60,141 4.05 % -0.83
Others 3,64,30,328 37.26 % -0.34

Category	Mar 2025	Dec 2024	Sep 2024	Jun 2024
Promoters	44.23	44.23	44.33	44.39
Pledge	7.92	7.92	7.90	90.41
FII	10.96	9.90	9.59	9.08
DII	7.55	8.27	8.18	7.61
Mutual Funds	4.05	4.89	5.09	5.03
Others	37.26	37.60	37.90	38.92

Category	No. of Shares	Percentage	% Change QoQ
Promoters	4,32,49,715	44.23 %	0.00
Pledge	34,25,000	7.92 %	0.00
FII	1,07,30,610	10.96 %	1.06
DII	73,80,255	7.55 %	-0.71
MF	39,60,141	4.05 %	-0.83
Others	3,64,30,328	37.26 %	-0.34

Shilpa Medicare MF Ownership

Bandhan Small Cap Direct-G
Equity: Small Cap
5.0
- 76.43
  Amount Invested (in Cr.)
- 0.75%
  % of AUM
- 0.00
  % Change (MoM basis)
ICICI Pru ELSS Tax Saver Direct-G
Equity: ELSS
2.0
- 66.84
  Amount Invested (in Cr.)
- 0.47%
  % of AUM
- 0.00
  % Change (MoM basis)
ICICI Pru Pharma Healthcare and Diagnostics (P.H.D) Direct-G
Equity: Sectoral-Pharma
4.0
- 62.32
  Amount Invested (in Cr.)
- 1.18%
  % of AUM
- 0.00
  % Change (MoM basis)

MF Ownership as on 30 April 2025

View all Mutual Fund Schemes

Shilpa Medicare Corporate Actions

Shilpa Medicare Board Meeting/AGM
Shilpa Medicare Dividends
Others

Meeting Date	Announced on	Purpose	Details
Feb 10, 2025	Feb 03, 2025	Board Meeting	Quarterly Results
Nov 13, 2024	Nov 04, 2024	Board Meeting	Quarterly Results
Aug 08, 2024	Jul 31, 2024	Board Meeting	Quarterly Results
May 23, 2024	May 16, 2024	Board Meeting	Audited Results & Final Dividend
Feb 08, 2024	Feb 01, 2024	Board Meeting	Quarterly Results

Type	Dividend	Dividend per Share	Ex-Dividend Date	Announced on
Final	110%	1.1	Sep 19, 2022	May 23, 2022
Final	110%	1.1	Sep 20, 2021	May 31, 2021
Interim	110%	1.1	Mar 16, 2020	Mar 03, 2020
Final	100%	1.0	Sep 12, 2019	May 27, 2019
Interim	70%	0.7	Mar 01, 2018	Feb 19, 2018

All Types	Ex-Date	Record Date	Announced on	Details
Splits	Nov 06, 2015	Nov 09, 2015	Aug 12, 2015	Split: Old FV2.0\| New FV:1.0
Bonus	Jul 16, 2013	-	May 29, 2013	Bonus Ratio: 1 share(s) for every 2 shares held
Splits	Sep 28, 2007	Oct 08, 2007	Apr 26, 2007	Split: Old FV10.0\| New FV:2.0

About Shilpa Medicare

Shilpa Medicare Ltd., incorporated in the year 1987, is a Small Cap company (having a market cap of Rs 6,546.61 Crore) operating in Pharmaceuticals sector. Shilpa Medicare Ltd. key Products/Revenue Segments include Formulations, Sale of services, Traded Goods, Power for the year ending 31-Mar-2024. Show More

Executives
Auditors

OI
Omprakash Inani
Chairman
VC
Vishnukant C Bhutada
Managing Director
KS
Kalakota Sharath Reddy
Whole Time Director
AB
Anita Bandyopadhyay
Independent Woman Director
AV
Arvind Vasudeva
Independent Director
HM
Hetal Madhukant Gandhi
Independent Director
KK
Kamal K Sharma
Independent Director
AM
Alpesh M Dalal
Chief Financial Officer
RT
Ritu Tiwary
Co. Secretary & Compl. Officer
Show More
Bohara Bhandari Bung & Associates LLP
Brahmayya & Co.

Industry

Pharma - Indian

Key Indices Listed on

BSE SmallCap, BSE Healthcare, BSE AllCap, + 6 more

Address

12-6-214/A-1,Shilpa House,Hyderabad Road,Raichur, Karnataka - 584135

Contact

[email protected]

http://www.vbshilpa.com

More Details

FAQs about Shilpa Medicare share

1. What is Shilpa Medicare share price and what are the returns for Shilpa Medicare share?
Shilpa Medicare share price is Rs 704.00 as on 20 May, 2025, 03:27 PM IST. Shilpa Medicare share price is down by 1.05% based on previous share price of Rs 707.95. Shilpa Medicare share price trend:
- Last 3 Months: Shilpa Medicare share price moved up by 3.29%
- Last 3 Years: Shilpa Medicare Share price moved up by 67.00%
2. Which are the key peers to Shilpa Medicare?
Within Pharmaceuticals sector Shilpa Medicare, Orchid Pharma Ltd., FDC Ltd., Strides Pharma Science Ltd., Aarti Pharmalabs Ltd., Supriya Lifescience Ltd., Akums Drugs & Pharmaceuticals Ltd., Innova Captab Ltd., Sun Pharma Advanced Research Company Ltd., Unichem Laboratories Ltd. and Hikal Ltd. are usually compared together by investors for analysis.
3. What are the key metrics to analyse Shilpa Medicare Share Price?
Shilpa Medicare share can be quickly analyzed on following metrics:
- Stock's PE is 77.91
- Price to Book Ratio of 3.87
4. What are the returns for Shilpa Medicare share?
Return Performance of Shilpa Medicare Shares:
- 1 Week: Shilpa Medicare share price moved up by 5.16%
- 3 Month: Shilpa Medicare share price moved up by 3.29%
- 6 Month: Shilpa Medicare share price moved down by 20.01%
5. Who are the key owners of Shilpa Medicare stock?
6. What is the CAGR of Shilpa Medicare?
The CAGR of Shilpa Medicare is 6.32.
7. What's the market capitalization of Shilpa Medicare?
Market Capitalization of Shilpa Medicare stock is Rs 6,855.14 Cr.
8. Who is the chairman of Shilpa Medicare?
Omprakash Inani is the Chairman of Shilpa Medicare
9. What is 52 week high/low of Shilpa Medicare share price?
In last 52 weeks Shilpa Medicare share had a high price of Rs 959.50 and low price of Rs 417.60
10. What dividend is Shilpa Medicare giving?
An equity Final dividend of Rs 1.1 per share was declared by Shilpa Medicare Ltd. on 23 May 2022. So, company has declared a dividend of 110% on face value of Rs 1 per share. The ex dividend date was 19 Sep 2022.
11. What are the Shilpa Medicare quarterly results?
Total Revenue and Earning for Shilpa Medicare for the year ending 2024-03-31 was Rs 1159.77 Cr and Rs 31.87 Cr on Consolidated basis. Last Quarter 2024-12-31, Shilpa Medicare reported an income of Rs 320.45 Cr and profit of Rs 31.78 Cr.
12. What is the PE & PB ratio of Shilpa Medicare?
The PE ratio of Shilpa Medicare stands at 78.8, while the PB ratio is 3.43.

Trending in Markets

Top Gainers As on 03:31 PM | 20 May 2025

Newgen Software1,334.55

186.90 (16.29%)

Pfizer4,949.80

481.81 (10.79%)

CCL Products830.70

72.56 (9.57%)

BASF India5,304.30

401.41 (8.19%)

Zensar Tech840.60

53.31 (6.77%)

Top Losers As on 03:31 PM | 20 May 2025

DOMS Industries2,548.80

-248.70 (-8.90%)

Cochin Shipyard1,817.60

-164.61 (-8.31%)

Bajaj Holdings12,932.00

-1041.00 (-7.46%)

Rites275.45

-19.49 (-6.61%)

HEG494.45

-34.26 (-6.48%)

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.

BrowseCompanies:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

1 2 3 4 5 6 7 8 9

1 Day	-0.2%
1 Week	6.33%
1 Month	5.84%
3 Months	4.19%
1 Year	41.72%
3 Years	68.7%
5 Years	102.3%

ETPrime

Shilpa Medicare Share Price

Shilpa Medicare share price insights

InsightsShilpa Medicare

Key Metrics

Key Metrics

Shilpa Medicare Share Price Returns

ET Stock ScreenersTop Score Companies

Shilpa Medicare News & Analysis

Shilpa Medicare Share Analysis

Unlock Stock Score, Analyst' Ratings & Recommendations

Shilpa Medicare Share Recommendations

Recent Recos

Analyst Trends

Shilpa Medicare Financials

Insights

Insights

Financial InsightsShilpa Medicare

Shilpa Medicare Share Price Forecast

Get multiple analysts’ prediction on Shilpa Medicare

Get multiple analysts’ prediction on Shilpa Medicare

Get multiple analysts’ prediction on Shilpa Medicare

Shilpa Medicare Technicals

Pivot Levels

Average True Range

Shilpa Medicare Peer Comparison

Ratio Performance

Peers InsightsShilpa Medicare

Shilpa Medicare Shareholding Pattern

Shilpa Medicare MF Ownership

Bandhan Small Cap Direct-G

ICICI Pru ELSS Tax Saver Direct-G

ICICI Pru Pharma Healthcare and Diagnostics (P.H.D) Direct-G

Shilpa Medicare Corporate Actions

About Shilpa Medicare

Executives

Auditors

More Details

FAQs about Shilpa Medicare share

Trending in Markets

Top Gainers As on 03:31 PM | 20 May 2025

Top Losers As on 03:31 PM | 20 May 2025

Shilpa Medicare Quick Links

Equity Quick Links

More from Markets